US4330001060 - Common Stock
HIMS & HERS HEALTH INC
NYSE:HIMS (12/20/2024, 8:16:42 PM)
After market: 26.38 +0.18 (+0.69%)26.2
-0.16 (-0.61%)
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,046 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. The company offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. The company offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.
HIMS & HERS HEALTH INC
2269 Chestnut St, #523
San Francisco CALIFORNIA 94123
P: 14158510195
CEO: Andrew Dudum
Employees: 1046
Website: https://www.forhims.com/
Hims & Hers stock is full of noise, but what's the signal for investors?
Compounders now have until late March to wind down their operations, depending on their licensing.
HIMS & HERS HEALTH INC (NYSE:HIMS) may be suited for growth investing, we'll explore why in this article.
Eli Lilly just gave investors several reasons to cheer.
Here you can normally see the latest stock twits on HIMS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: